MétaCan
Menu
Back to cohort
Record W2000467119 · doi:10.1016/j.jalz.2011.05.1056

P2‐169: NSAID use does not affect dementia progression or survival in Alzheimer's disease. The Cache County Dementia Progression Study.

2011· article· en· W2000467119 on OpenAlexaff
Trevor Buckley, Chris Corcoran, Sarah Schwartz, John C.S. Breitner, Peter P. Zandi, Maria C. Norton, M. Scott DeBerard, Heidi J. Wengreen, Beth Foley, Kathleen A. Welsh‐Bohmer, Constantine G. Lyketsos, JoAnn T. Tschanz

Bibliographic record

VenueAlzheimer s & Dementia · 2011
Typearticle
Languageen
FieldNeuroscience
TopicTryptophan and brain disorders
Canadian institutionsMcGill University
Fundersnot available
KeywordsDementiaMedicineClinical Dementia RatingAlzheimer's diseasePopulationProportional hazards modelRating scaleDiseaseInternal medicinePsychology

Abstract

fetched live from OpenAlex

Non-steroidal anti-inflammatory medications (NSAIDs) may be associated with reduced incidence of Alzheimer's Disease (AD). However, their effects after the onset of dementia are unclear. We examined whether NSAID use before and after the onset of dementia and total duration of use affected dementia progression in a population-based incident sample of AD with up to 8 years of follow-up. Participants were 328 persons with Possible/Probable AD (66% female). Lifetime and current NSAID use was ascertained in an interview and with visual inspection of the participant's medications. Updates were obtained with the participant prior to the onset of dementia and a caregiver thereafter. NSAID use was coded if the participant used NSAIDs at least once a week for a month or longer. Pattern of use was summarized as: before dementia onset, after onset, or both. Total duration of NSAID use was also determined. Participants were tested every 6-18 months after diagnosis with the Mini-Mental State Exam, a global measure of cognition, and the Clinical Dementia Rating Scale Sum-of-Boxes, a measure of function. Multivariable linear mixed models examined whether NSAID use or cumulative duration predicted cognitive or functional progression in dementia. Survival was examined using Cox Regression. Interactions between NSAID use and APOE genotype were tested, adjusting for dementia duration, age, gender, and education. NSAIDs were used by 17% of participants prior to dementia onset, 10% after onset, and 29% both before and after onset. Forty-four percent reported no regular use. Mean (SD) duration of use was 4.68 (6.34) years prior to dementia onset and 1.46 (1.72) years after onset. Participants were followed for a mean (SD) of 3.13 (2.47) years after diagnosis. Neither NSAID use nor duration of use predicted cognitive (p > 0.50) or functional decline (p > 0.40) regardless of timing of use. NSAID use prior to dementia onset was associated with slightly increased mortality risk (Hazard Ratio = 1.13, p = 0.07), while duration of use had no association with mortality risk (p = 0.41). In this sample of incident AD, we found no effect of NSAIDs on dementia progression. The slight increase in risk of mortality may warrant further study.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.023
Threshold uncertainty score0.047

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.001
Science and technology studies0.0010.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.085
GPT teacher head0.321
Teacher spread0.236 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2011
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicTryptophan and brain disordersFrench-language works237,207